What Is Cinchonine? Definition and What Research Reports

Definition

Cinchonine is a naturally occurring quinoline alkaloid obtained from the bark of Cinchona trees, the same botanical source that yields quinine, quinidine and cinchonidine. Structurally it consists of a quinoline ring linked by a carbinol bridge to a quinuclidine ring bearing a vinyl group, and it is the stereoisomer (diastereomer) of cinchonidine. Reviews of the Cinchona alkaloid family have described the group's chemistry, the range of semi-synthetic derivatives prepared from the natural scaffolds, and their applications across medicinal chemistry and catalysis (PMID 30850032). A dedicated pharmacological review published in 2024 characterised cinchonine as a versatile agent derived from these natural alkaloids and catalogued the biological activities reported for it (PMID 38031797).

What Class of Molecule Is It?

Cinchonine is a small-molecule alkaloid, not a peptide, protein or peptide fragment. Alkaloids are nitrogen-containing secondary metabolites produced by plants; cinchonine's nitrogen atoms sit in the quinoline and quinuclidine rings, which makes it a base capable of forming salts with acids. Crystallographic work has characterised such salt forms, including the structure of cinchoninium L-tartrate tetrahydrate (PMID 11740113). Salt formation of this kind is one reason the Cinchona alkaloids have long been used in classical resolution of racemic mixtures.

Where the Term Appears in Peptide-Adjacent Research

Because PeptideU catalogues terms that surface alongside peptide literature, it is worth stating plainly how cinchonine is used in that context. The term appears in three recurring ways:

• As a chiral scaffold in synthetic chemistry. Cinchona alkaloids and their derivatives have been described as widely applied structures in asymmetric synthesis and derivative design, a role summarised in a monograph chapter on Cinchona alkaloid derivatives and applications (PMID 30850032). Peptide chemists encounter such scaffolds as organocatalysts or resolving agents rather than as biological actives.
• As a hybrid-building partner. Researchers have covalently combined Cinchona alkaloids with other biomolecules to create hybrid compounds; one 2019 report described hybrids of Cinchona alkaloids and bile acids evaluated as antiparasitic agents against Trypanosoma cruzi (PMID 31480402).
• As a comparator small molecule in mechanism studies. Cell-signalling papers that also involve peptides or protein targets sometimes include cinchonine because of its documented effects on specific intracellular pathways, discussed below.

What the Published Literature Reports

Cancer cell and tumour-model work

A substantial share of the cinchonine literature is preclinical oncology. A 2017 study reported that cinchonine induced apoptosis in HeLa and A549 cell lines and identified TRAF6 as a molecular target in that setting (PMID 28231796). A 2023 paper reported cinchonine-induced cell death in pancreatic cancer cells associated with downregulation of RRP15 (PMID 36682038). Separately, researchers reported in 2023 that cinchonine exerted anti-tumour and immunotherapy-sensitising effects in lung cancer models by impairing autophagic–lysosomal degradation (PMID 37301135). A 2025 comprehensive review collected these cellular and molecular mechanisms alongside the compound's botanical source and pharmacokinetic properties (PMID 41078318).

Metabolic and adipose-tissue models

In a 2012 study, researchers reported that cinchonine prevented high-fat-diet-induced obesity in a rodent model, with the authors attributing the effect to downregulation of adipogenesis and of adipose tissue inflammation (PMID 22675336). That work sits within the PPAR-related literature and, as with all of the entries summarised here, was conducted in animals rather than in humans.

Bone cell differentiation

A 2021 report described cinchonine inhibiting osteoclast differentiation through regulation of TAK1 and AKT signalling while promoting osteogenesis in the same experimental system (PMID 32700766). This is one of the few non-oncology mechanistic threads in the cinchonine literature.

Antiviral and antimicrobial screening

A 2022 study reported that cinchonine inhibited porcine epidemic diarrhea virus in cell culture, with the authors describing induction of cellular autophagy as the proposed mechanism (PMID 35774410). On the antibacterial side, a 2021 paper evaluated antimicrobial activity of quasi-enantiomeric Cinchona alkaloid derivatives and developed a machine-learning prediction model from the resulting data (PMID 34073082). Antiparasitic activity has been explored through the bile-acid hybrid series noted above (PMID 31480402).

Safety and Tolerability: What Studies Report

The verified literature summarised on this page is overwhelmingly preclinical — cell culture and animal models — and does not establish a human safety profile for cinchonine as an intervention. The 2024 pharmacological review framed cinchonine as a versatile agent derived from Cinchona alkaloids and surveyed its reported activities (PMID 38031797), while the 2025 review additionally discussed pharmacokinetic properties alongside the mechanistic data (PMID 41078318). No human dosing information is presented here because none of the verified sources supports it. This page is for educational purposes only and is not medical advice; consult a licensed physician before making any health decision.

How the Term Is Commonly Confused

• Cinchonine vs. quinine. Both are Cinchona alkaloids, but they are distinct molecules; quinine's long antimalarial history does not transfer to cinchonine, and the reviews treat the family members separately (PMID 30850032).
• Cinchonine vs. cinchonidine. These are stereoisomers, discussed within the same alkaloid-derivative literature (PMID 30850032).
• Cinchonine vs. a peptide. Cinchonine is a plant alkaloid with no amino acid backbone; it is indexed here as a glossary cross-reference, not as a peptide.
• Free base vs. salt. Research materials may appear as salts such as cinchoninium tartrate, a form characterised crystallographically (PMID 11740113).

Summary of the Evidence Base

1. Cinchonine is a defined natural product with well-characterised chemistry and salt forms (PMID 11740113).
2. The largest body of published work is preclinical oncology across cervical, lung and pancreatic cell models (PMID 28231796, PMID 37301135, PMID 36682038).
3. Smaller threads cover metabolic, skeletal, antiviral and antimicrobial endpoints (PMID 22675336, PMID 32700766, PMID 35774410, PMID 34073082).
4. Two recent reviews consolidate the mechanistic picture (PMID 38031797, PMID 41078318).

References

• Cinchoninium L-tartrate tetrahydrate (Acta Crystallographica Section C, 2001)
• Cinchonine: A Versatile Pharmacological Agent Derived from Natural Cinchona Alkaloids (Current Topics in Medicinal Chemistry, 2024)
• Cinchona Alkaloids-Derivatives and Applications (The Alkaloids: Chemistry and Biology, 2019)
• Exploring the Anticancer Properties of Cinchonine: A Comprehensive Review of Cellular and Molecular Mechanisms With Botanical Source and Pharmacokinetics Property (Journal of Biochemical and Molecular Toxicology, 2025)
• Cinchonine Prevents High-Fat-Diet-Induced Obesity through Downregulation of Adipogenesis and Adipose Inflammation (PPAR Research, 2012)
• Cinchonine exerts anti-tumor and immunotherapy sensitizing effects in lung cancer by impairing autophagic-lysosomal degradation (Biomedicine & Pharmacotherapy, 2023)
• Cinchonine-induced cell death in pancreatic cancer cells by downregulating RRP15 (Cell Biology International, 2023)
• Hybrids of Cinchona Alkaloids and Bile Acids as Antiparasitic Agents Against Trypanosoma cruzi (Molecules, 2019)
• Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis (Journal of Cellular Physiology, 2021)
• Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6 (Journal of Experimental & Clinical Cancer Research, 2017)
• Inhibition of Porcine Epidemic Diarrhea Virus by Cinchonine via Inducing Cellular Autophagy (Frontiers in Cellular and Infection Microbiology, 2022)
• Antimicrobial Activity of Quasi-Enantiomeric Cinchona Alkaloid Derivatives and Prediction Model Developed by Machine Learning (Antibiotics, 2021)